Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/3209
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMuhammadiyeva S.M., Jovliyeva D.N., Isakova E.I., Kamalova D.K., Mad’iyeva I.O., Ismailova Z.SH.-
dc.date.accessioned2022-10-11T12:00:17Z-
dc.date.available2022-10-11T12:00:17Z-
dc.date.issued2022-03-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/3209-
dc.description.abstractTadqiqot maqsadi: Osteoartritda (OA) diaserin preparatining klinik samaradorligi va xavfsizligini o’rganish. Tekshiruv materiallari va usullari. Biz Toshkent tibbiyot akademiyasi (TTA) koʿp tarmoqli klinikasining revmatologiya va artrologiya boʿlimida davolash kursini olgan 36 yoshdan 81 yoshgacha (oʿrtacha yosh 54) yoshdagi 40 nafar osteoartritli bemorlarni kuzatdik. Shundan 7 nafari (17,5%) erkaklar, 33 nafari (82,5%) ayollardir. Biz tomonimizdan oʿrganilgan bemorlarning kasallikning boshlanishida oʿrtacha yoshi taxminan 54 yoshni tashkil etdi. Tadqiqot natijalari shuni ko’rsatdiki, Diasеrin preparati o’z ta’sirini diklofenakdan kechroq, 7-8 kunlarda namoyon qiladi, ammo uzoq muddatli yallig’lanishga qarshi va og’riq qoldiruvchi ta’sirga ega.en_US
dc.language.isootheren_US
dc.publisherUzbekistanen_US
dc.relation.ispartofseriesУДК;616.72 – 002 – 085: 616 - 092-
dc.subjectOsteoartroz, davolash, nosteroid yallig ʿlanishga qarshi dori vositalari, diatserein, diklofenak.en_US
dc.titleOsteoartroz kasalligini sekin taʿsir qiluvchi diaserin vositasi bilan davolash samaradorligien_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
3.Мухаммадиева С.М.1_вестн 2. 2022. (2).pdfстатья739.22 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.